Scaling oligonucleotide manufacturing: what changes between a research column and a production batch, how oligonucleotide manufacturers and any one oligonucleotide manufacturer quote it, where oligonucleotide analysis fits in release, why purification rather than coupling sets the cost at scale, and the change control a supply agreement has to name

What changes with scale

1. Coupling efficiency compounds, so length is the cost driver. Each addition is a chemical step at slightly less than complete efficiency, and the full length yield falls geometrically with length. That is why a long oligonucleotide costs disproportionately more and why purification matters more the longer it gets.
2. Purification, not synthesis, sets the cost at scale. Desalted material is cheap; cartridge, high performance liquid chromatography and gel purification each add a step and a yield loss. Specify the purification the application actually needs, because buying gel purity for a screening primer is a large recurring waste.
3. Modifications multiply everything. Every dye, quencher, phosphorothioate linkage or modified base is a separate reagent with its own coupling behaviour and its own cost, and some combinations constrain the purification route. List every modification when asking for a quotation.
4. Fix the release testing in the specification. Mass spectrometry confirming identity, a purity measurement by a stated method, and concentration by absorbance are the usual release package. A certificate that reports concentration alone is a shipping note rather than a release.
5. Write change control into the supply agreement. A supplier changing a synthesis site, a reagent source or a purification route can shift impurity profiles in ways an assay will feel. Notification with lead time, and lot reservation, are the terms worth more than a small price difference.

Impurities, and which ones matter

Truncated sequences from incomplete coupling, depurinated material, and residues of protecting groups and reagents are the usual impurity classes. Which matter depends on the application: a truncation that is invisible in a polymerase chain reaction can ruin an antisense experiment.

Ask what the impurity profile looks like for your purification grade, and whether the supplier measures it routinely or on request. The answer tells you a good deal about the operation.

Formats and delivery

Plates, tubes, dried or in solution, normalised to concentration or supplied at yield. For anything automated, the plate format and the normalisation are what decide how much handling arrives with the order.

Normalised plates cost more and remove a quantification and dilution step from every user. At volume that is usually the cheaper arrangement.

Storage and stability

Dried at low temperature is the stable form; in solution the rate depends on the buffer and on whether it is nuclease free. Aliquot on arrival and record the date, because a stock diluted and refrozen repeatedly degrades measurably.

For modified oligonucleotides, follow the supplier's storage instruction rather than the general rule. Dyes and some modifications are considerably less stable than the backbone.

Common questions

Why does a longer oligonucleotide cost so much more?

Because coupling efficiency compounds. Each addition is slightly less than complete, so the proportion of full length product falls geometrically with length, and more material must be made and purified to deliver the same amount.

What purification do I actually need?

Desalted for routine primers, cartridge or chromatographic purification for probes and anything where truncated sequences interfere, and the highest grades for therapeutic or diagnostic applications. Buying above the need is a large recurring cost.

What should a certificate of analysis show?

Identity by mass spectrometry against the expected mass, purity by a named method with the value, and concentration with the method used. Those three make the material traceable; a concentration alone does not.

How do I secure supply for a product?

A supply agreement with change notification, lot reservation, an agreed specification and a stated lead time, plus a qualified second source where the volume justifies the second validation.

Browse by service class

• Compare Gene synthesis on advertised prices